BullBD Old Apps Site
Home
Favorites
Recently viewed Details Chart Today news Share news Top gainer Top Looser Upcoming events
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0 1 2 3 4 5 6 7 8 9 All
Bank Cement Ceramics Sector Corporate Bond Engineering Financial Institutions Food & Allied Fuel & Power IT Sector Insurance Jute Life Insurance Miscellaneous Mutual Funds Paper & Printing Pharmaceuticals & Chemicals Services & Real Estate Tannery Industries Telecommunication Textile Travel & Leisure All
  • Details
  • Chart
  • News

SAMORITA

All Eps Dividend Board Agm Q1 Q2 Q3

SAMORITA 02-Nov-2020

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 09, 2020 at 6:30 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended on September 30, 2020.

SAMORITA 02-Nov-2020

As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 09, 2020 at 6:30 PM to consider, among others, audited financial statements of the Company for the year ended on June 30, 2020.

SAMORITA 19-Jul-2020

The Company has informed that the Board of Directors has elected Prof. Reaz Ahmed Chowdhury as the Chairman and Mr. Mojibul Islam as the Vice Chairman of the Company.

SAMORITA 12-Jul-2020

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on July 18, 2020 at 11:00 AM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended on March 31, 2020.

SAMORITA 19-Jan-2020

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on January 25, 2020 at 7:30 PM to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended on December 31, 2019.

SAMORITA 06-Nov-2019

The Board of Directors has recommended 10% cash and 5% stock dividend for the year ended on June 30, 2019. Date of AGM: 29.12.2019, Time: 11:30 AM, Venue: MH Samorita Hospital & Medical College, 117 Tejgaon, Love Road, Dhaka. Record Date: 02.12.2019. The Company has also reported EPS of Tk. 1.79, NAV per share of Tk. 52.55 and NOCFPS of Tk. 2.76 for the year ended on June 30, 2019 as against Tk. 1.31, Tk. 51.95 and Tk. 2.35 respectively for the same period of the previous year.

SAMORITA 28-Oct-2019

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 05, 2019 at 7:30 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended on September 30, 2019.

SAMORITA 28-Oct-2019

As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 05, 2019 at 7:30 PM to consider, among others, audited financial statements of the Company for the year ended on June 30, 2019.

SAMORITA 16-Jul-2019

The Company has informed that the Board of Directors of the Company has decided to purchase a land measuring 2.18 Kathas including one 04 (Four) storied building measuring 5,000 sft. adjacent to Samorita Hospital premises at a cost of Tk. 2.90 crore only excluding registration and other related expenses at Mouza- Raja Bazar, PS- Sher-E-Banglanagar, Dist- Dhaka. The space of the building will be used for doctors' consultation centre.

SAMORITA 08-Apr-2019

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on April 16, 2019 at 7:30 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended on March 31, 2019.

Previous Next page